WeVote
Log In

Bill

Bill

HB 563

Controlled substances; provide for automatic scheduling of psilocybin after federal scheduling.

2026 Regular Session Introduced by Sam Creekmore

Mississippi bill creates automatic state rescheduling of psilocybin to match federal scheduling changes without requiring legislative action.

Title Suff Do Pass
#drugpolicy
0
WeVote Research Nonpartisan
Bill Summary · HB 563

Legislative bill overview

HB 563 would establish an automatic scheduling mechanism in Mississippi state law that aligns the state's controlled substance schedules with federal scheduling decisions for psilocybin. This means if psilocybin is rescheduled at the federal level, Mississippi's classification would automatically update without requiring new legislative action.

Why is this important

Psilocybin's legal status is currently evolving nationally—the DEA is reviewing its scheduling, and several jurisdictions have decriminalized or are researching its therapeutic potential for mental health conditions. This bill addresses the practical question of how Mississippi would respond to potential federal reclassification, avoiding a legislative lag period where state and federal law might diverge. It reflects broader policy questions about state autonomy versus federal alignment on drug scheduling.

Potential points of contention

  • Automatic vs. deliberative action: Critics may argue the state legislature should actively debate psilocybin policy rather than ceding that decision-making authority to automatic federal alignment
  • Medical research concerns: Some may support automatic rescheduling if federal changes enable mental health research, while others may oppose enabling access to a Schedule I substance
  • Sovereignty questions: The bill raises federalism debates about whether states should independently evaluate controlled substances or defer to federal determinations

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.